倾向性评分分析活跃远端和广泛性结肠炎的临床特征:一项回顾性研究
Changchang Ge1, Zhaofeng Shen1, Yi Lu1
1Jiangsu Provincial Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Frontiers in physiology
|July 17, 2023
概括
这项研究揭示了基于疾病程度的性结肠炎 (UC) 独特的临床标志物. 识别这些差异有助于理解UC病原体和开发有针对性的治疗方法.
科学领域:
- 胃肠病学 胃肠病学
- 临床医学 临床医学
- 生物标志物发现发现
背景情况:
- 基于疾病程度的性结肠炎 (UC) 亚型对于理解病理生理学至关重要.
- 分析不同疾病范围的UC的临床特征可以改善病原研究,疾病监测和治疗.
研究的目的:
- 分析和比较性结肠炎患者的临床特征与远端结肠炎和广泛性结肠炎.
- 识别差异性临床指标及其对疾病严重程度的预测值 (梅奥内镜子评分).
主要方法:
- 188名患有活跃UC的患者被分为远端结肠炎和广泛结肠炎组.
- 倾向性得分匹配用于分析临床特征.
- 使用斯皮尔曼相关性和ROC曲线分析来评估临床指标并预测梅奥内镜子评分 (MES).
主要成果:
- 扩散性结肠炎显示出比远端结肠炎更严重的疾病活动,年龄更小,使用更多的皮质类固醇,以及更多的肠外表现 (EIMs).
- 炎症,凝血和免疫标志物 (例如,CRP,D-二次体) 在广泛性结肠炎中较高,而代谢标志物 (例如,LDL-C,白蛋白) 在偏远性结肠炎中较高.
- 生物标志物的特定组合 (例如,偏远结肠炎的CRP + D-二分体 + α2-MG;广泛结肠炎的IL-6 + GSP + α1-MG) 显示了MES3的高预测准确性.
结论:
- 不同的临床指标作为预测UC进展和预后的潜在标志物.
- 这些生物标志物对UC机制研究和药物开发具有重要意义.
- 生物标志物选择可以根据性结肠炎的病变部位进行定制.
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
222
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
222
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
157
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
157
01:29Drugs for Treatment of Ulcerative Colitis in IBD
175
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
175
01:30Inflammatory Bowel Disease II: Crohn's Disease
298
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
298
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
357
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
357
01:28Peptic Ulcer Disease II: Pathophysiology
540
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
540